-
1
المؤلفون: Marie Villumsen, Espen Jimenez-Solem, Astrid Blicher Schelde, Tine Jess, Kristine Højgaard Allin
المصدر: EClinicalMedicine, Vol 37, Iss, Pp 100979-(2021)
Villumsen, M, Schelde, A B, Jimenez-Solem, E, Jess, T & Allin, K H 2021, ' GLP-1 based therapies and disease course of inflammatory bowel disease ', EClinicalMedicine, vol. 37, 100979 . https://doi.org/10.1016/j.eclinm.2021.100979
EClinicalMedicineمصطلحات موضوعية: Drug, medicine.medical_specialty, Medicine (General), IMID, immune-mediated inflammatory disease, media_common.quotation_subject, Colitis ulcerative, GLP, glucagon-like-peptide, Type 2 diabetes, SGLT2, Sodium-glucose Cotransporter-2, Lower risk, 01 natural sciences, TNF, tumour necrosis factor, Inflammatory bowel disease, 03 medical and health sciences, 0302 clinical medicine, R5-920, Internal medicine, Dipeptidyl peptidase-4 inhibitors, medicine, 030212 general & internal medicine, 0101 mathematics, Medical prescription, media_common, Glucagon-like-peptide 1 receptor agonists, ATC, Anatomical Therapeutic Chemical, Crohn's disease, IBD, inflammatory bowel disease, business.industry, Pharmacoepidemiology, 010102 general mathematics, General Medicine, medicine.disease, Prognosis, Ulcerative colitis, PY, person-years, ICD, International Classification of Diseases, IR, incidence rate, Metformin, UC, ulcerative colitis, IRR, incidence rate ratios, DPP, dipeptidyl peptidase, CD, Crohn's disease, business, Research Paper, medicine.drug
وصف الملف: application/pdf
-
2
المؤلفون: Silvia Pérez-Barrio, Lucy Moorhead, Manpreet Lakhan, Saskia Reeken, Vito Zeeshaan Hasab, Rogelio Mercado-Seda, Gustavo Anibal Cardozo, Georgi Popov, Enrique Loayza, Marie-Louise Svensson, Emmanuel Mahe, Fernando Valenzuela, Victoria King, Michela Magnano, Danielle Brassard, Annette Essex, Deanna Cummings, Manisha Panchal, Trupti V. Desai, Jennifer E. Carolan, Areti Makrygeorgou, Zenas Z N Yiu, Teena Mackenzie, Esteban Daudén, Emmanuel Toni, Ian Pearson, Andrea Carugno, Lorraine Gribben, Leontien de Graaf, Liv Eidsmo, Esther A. Balogh, Gloria Aparicio, Andrew Pink, Manel Velasco, Adrienne J. van Geest, Steven R. Feldman, Tiago Torres, Elzbieta Klujszo, Malcolm H.A. Rustin, Ignacio Yanguas, Anthony Bewley, Eliseo Martínez-García, Benhadou Farida, Emily Dwyer, Susannah Hoey, Richard B. Warren, Esther E. Freeman, Diana Ruiz Genao, Rohima Khatun, Giulia Rech, Elena B. Hawryluk, Zahira Koreja, Ricardo Romiti, Gonzalez A. Cesar, Alice Mwale, Charlotte Barclay, Aadarsh Shah, Catherine Quinlan, Kathryn G. Kerisit, Christopher E.M. Griffiths, Carla Tubau Prims, Lone Skov, Céline Phan, Vincent Descamps, Jenny Hughes, Siew Eng Choon, Shanti Ayob, Efrossini Carras, Girard Celine, Jo Lambert, Alberto Barea, Jonathan Barker, Reinhart Speeckaert, Raquel Rivera, Portia Goldsmith, Nick Dand, Beatriz Pérez-Suárez, Andrew DeCrescenzo, F. Meynell, Francesca Capon, Toomas Talme, Teresa Tsakok, Deepti Kolli, Stefano Piaserico, Jamie Weisman, Manuel D. Franco, K.J. Mason, Pablo De Caso, Catriona Maybury, Rachel Bak, Ann Sergeant, Keith Wu, Graham A. Johnston, Alexandra Paolino, Cécile Lesort, Mark Vandaele, H. McAteer, Birgitta Wilson Claréus, Sinead Langan, Jose-Manuel Carrascosa, Enikö Sonkoly, Claudia de la Cruz, Maruska Marovt, Luigi Naldi, Leila Asfour, Paola Di Meglio, Jose-Maria Ortiz-Salvador, Alekya Singapore, Peter Jenkin, Romana Ceovic, R. Taberner, P.J. Hampton, Alberto Romero-Maté, Russell W. Cohen, Omid Zargari, Maria Teresa Rossi, Devon E. McMahon, Denis Jullien, Bola Coker, Carrie Davis, Georgie King, Catherine H. Smith, Richard Woolf, Luis Puig, Ann Jones, Astrid van Huizen, Joseph J. Schwartz, Paolo Gisondi, Phyllis I. Spuls, Satveer K. Mahil, Sarah Kirk, Paulo Varela, K. Jackson, Ana Maria Morales Callaghan, Vito Di Lernia, Lieve Meuleman, Claudio Greco, Simina Stefanescu, Hervé Bachelez, Ana Martinez
المساهمون: Dermatology, AII - Inflammatory diseases, APH - Methodology, APH - Quality of Care, Mahil, S, Dand, N, Mason, K, Yiu, Z, Tsakok, T, Meynell, F, Coker, B, Mcateer, H, Moorhead, L, Mackenzie, T, Rossi, M, Rivera, R, Mahe, E, Carugno, A, Magnano, M, Rech, G, Balogh, E, Feldman, S, De La Cruz, C, Choon, S, Naldi, L, Lambert, J, Spuls, P, Jullien, D, Bachelez, H, Mcmahon, D, Freeman, E, Gisondi, P, Puig, L, Warren, R, Di Meglio, P, Langan, S, Capon, F, Griffiths, C, Barker, J, Smith, C, Shah, A, Barea, A, Romero-Mate, A, Singapore, A, Paolino, A, Mwale, A, Morales Callaghan, A, Martinez, A, Decrescenzo, A, Pink, A, Jones, A, Sergeant, A, Essex, A, Bewley, A, Makrygeorgou, A, van Huizen, A, Perez-Suarez, B, Farida, B, Clareus, B, Prims, C, Davis, C, Quinlan, C, Maybury, C, Cesar, G, Barclay, C, Greco, C, Brassard, D, Cummings, D, Kolli, D, Descamps, V, Genao, D, Carras, E, Hawryluk, E, Martinez-Garcia, E, Klujszo, E, Dwyer, E, Toni, E, Sonkoly, E, Loayza, E, Dauden, E, Valenzuela, F, Popov, G, King, G, Celine, G, Aparicio, G, Johnston, G, Cardozo, G, Pearson, I, Yanguas, I, Weisman, J, Carolan, J, Hughes, J, Ortiz-Salvador, J, Carrascosa, J, Schwartz, J, Jackson, K, Kerisit, K, Wu, K, Asfour, L, de Graaf, L, Lesort, C, Meuleman, L, Eidsmo, L, Skov, L, Gribben, L, Rustin, M, Velasco, M, Panchal, M, Lakhan, M, Franco, M, Svensson, M, Vandaele, M, Marovt, M, Zargari, O, De Caso, P, Varela, P, Jenkin, P, Phan, C, Hampton, P, Goldsmith, P, Bak, R, Speeckaert, R, Romiti, R, Woolf, R, Mercado-Seda, R, Khatun, R, Ceovic, R, Taberner, R, Cohen, R, Stefanescu, S, Kirk, S, Reeken, S, Ayob, S, Perez-Barrio, S, Piaserico, S, Hoey, S, Torres, T, Talme, T, Desai, T, van Geest, A, King, V, Di Lernia, V, Koreja, Z, Hasab, V
المصدر: PsoProtect study group 2020, ' Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study ', The Journal of allergy and clinical immunology . https://doi.org/10.1016/j.jaci.2020.10.007
The Journal of Allergy and Clinical Immunology
Journal of allergy and clinical immunology, 147(1), 60-71. Mosby Inc.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Journal of Allergy and Clinical Immunologyمصطلحات موضوعية: Male, IMID, immune-mediated inflammatory disease, immunosuppressant, BMI, body mass index, ACEi, angiotensin-converting enzyme inhibitor, PsoProtect, Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of COVID-19 infecTion, Logistic regression, Systemic therapy, 030207 dermatology & venereal diseases, 0302 clinical medicine, RC705, Interquartile range, COVID-19, biologics, hospitalization, immunosuppressants, psoriasis, risk factors, Risk Factors, Epidemiology, Immunology and Allergy, 030212 general & internal medicine, Registries, NSAID, non-steroidal anti-inflammatory drug, 610 Medicine & health, COVID-19, Coronavirus disease 2019, TNF, tumor necrosis factor, Age Factors, Middle Aged, Hospitalization, risk factor, 95% CI, 95% confidence interval, Female, JAK, Janus kinase, biologic, Adult, medicine.medical_specialty, Immunology, Lower risk, SARS-CoV-2, severe acute respiratory syndrome coronavirus 2, Article, 03 medical and health sciences, Sex Factors, Internal medicine, Psoriasis, medicine, Humans, SARS-CoV-2, IFN, interferon, IQR, interquartile range, psoriasi, business.industry, Odds ratio, medicine.disease, ARB, angiotensin II receptor blocker, IL, interleukin, OR, odds ratio, business, Body mass index
وصف الملف: application/pdf; STAMPA
-
3
المؤلفون: Vicky Margarita Montaño Mendoza
المصدر: Journal of Infection
The Journal of Infectionمصطلحات موضوعية: Microbiology (medical), 2019-20 coronavirus outbreak, Coronavirus disease 2019 (COVID-19), Pneumonia, Viral, GM-CSF, Granulocyte-macrophage colony stimulating factor, TGF-β, Transforming growth factor-beta, Lung injury, Betacoronavirus, SARS-CoV-2, Severe acute respiratory syndrome coronavirus-2, MCP-1, Monocyte chemoattractant protein-1, IMID: Immune-mediated inflammatory disease, CS, Cytokine storm, IP-10, Interferon γ-induced protein 10, ROR, Retinoic acid receptor-related orphan receptor gamma, Pandemic, medicine, Humans, IL, Interleukin, lung injury, Letter to the Editor, Pandemics, G-CSF, Granulocyte-colony stimulating factor, COVID-19, Coronavirus disease 2019, MIP3A, Macrophage Inflammatory Protein-3, biology, SARS-CoV-2, business.industry, Interleukin-17, TNF, Tumor necrosis factor, COVID-19, biology.organism_classification, medicine.disease, Virology, IFN, Interferon, IL-17, Infectious Diseases, cytokine storm, CXCL, Chemokine ligand, immunomodulatory therapy, Interleukin 17, JAK, Janus kinase, Coronavirus Infections, Cytokine storm, business, STAT, Signal transducer and activator of transcription
-
4
المؤلفون: Wilkinson, Nina, Tsakok, Teresa, Dand, Nick, Bloem, Karien, Duckworth, Michael, Baudry, David, Pushpa-Rajah, Angela, Griffiths, Christopher E.M., Reynolds, Nick J., Barker, Jonathan, Warren, Richard B., Burden, A. David, Rispens, Theo, Stocken, Deborah, Smith, Catherine
المصدر: Wilkinson, N, Tsakok, T, Dand, N, Bloem, K, Duckworth, M, Baudry, D, Pushpa-Rajah, A, Griffiths, C EM, Reynolds, N J, Barker, J, Warren, R B, Burden, A D, Rispens, T, Stocken, D & Smith, C 2019, ' Defining the therapeutic range for adalimumab and predicting response in psoriasis : a multicenter prospective observational cohort study ', Journal of Investigative Dermatology, vol. 139, no. 1, pp. 115-123 . https://doi.org/10.1016/j.jid.2018.07.028
The Journal of Investigative Dermatologyمصطلحات موضوعية: IMID, immune-mediated inflammatory disease, IBD, inflammatory bowel disease, Tumor Necrosis Factor-alpha, BADBIR, British Association of Dermatologists Biologic Interventions Registry, Adalimumab, RA, rheumatoid arthritis, Antibodies, Monoclonal, PASI, Psoriasis Area and Severity Index, Antibodies, Monoclonal, Humanized, Article, BSTOP, Biomarkers of Systemic Treatment Outcomes in Psoriasis, Etanercept, CI, confidence interval, PASI90, 90% improvement in baseline Psoriasis Area and Severity Index, Cohort Studies, PASI75, 75% improvement in baseline Psoriasis Area and Severity Index, Humans, Psoriasis, Prospective Studies, ADA, anti-drug antibody
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::7fb02c669a37546deaa81518faf9005d
https://eprints.gla.ac.uk/212827/1/212827.pdf -
5دورية أكاديمية
المؤلفون: Villumsen M; Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, The Capital Region, Copenhagen, Denmark., Schelde AB; Department of Clinical Pharmacology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark., Jimenez-Solem E; Department of Clinical Pharmacology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark.; Copenhagen Phase IV unit (Phase4CPH), Department of Clinical Pharmacology and Center of Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark., Jess T; Center for Molecular Prediction of Inflammatory Bowel Disease, Department of Clinical Medicine, Aalborg University, Copenhagen, Denmark., Allin KH; Center for Molecular Prediction of Inflammatory Bowel Disease, Department of Clinical Medicine, Aalborg University, Copenhagen, Denmark.
المصدر: EClinicalMedicine [EClinicalMedicine] 2021 Jun 23; Vol. 37, pp. 100979. Date of Electronic Publication: 2021 Jun 23 (Print Publication: 2021).
نوع المنشور: Journal Article
بيانات الدورية: Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE
Full Text via ClinicalKey 
Full Text Finder